Ραυτόπουλος Ιωάννης

Ερευνητικό Ενδιαφέρον

• Co-Investigator, US National Trial regulated by the Federal Drug Administration (F.D.A.): The Enlighten Study regarding the Elipse swallowable gastric balloon for weight loss requiring no sedation or anesthesia 2017 – present
• Co-Investigator, European Trial for the Elipse swallowable gastric balloon for weight loss, 2014-2016. Based on the trial’s results the Elipse balloon received the CE mark for commercial use in European Union
• Raftopoulos Y, Davidson E. “Laparoscopic Roux-en-Y gastric bypass without opioids. Is it possible? Effect of restricted opioid usage on an established 1-day fast-track protocol for laparoscopic Roux-en-Y gastric bypass.” Accepted as oral presentation to the American College of Surgeons’ 2017 Clinical Congress (October 22-26), in San Diego, CA.
• Raftopoulos I, Giannakou A, Kandiliotis I, Bojkova M, Kupka T, Buzga M, Stecco K, Levy S, Gaur S, Chuttani R, Machytka E. The First Procedureless Gastric Balloon for Weight Loss: Final Results from a Multi-Center, Prospective Study Evaluating Safety, Efficacy, Participant Preference, and Long Term Follow-Up. Obesity Week, October 31-November 4, 2016, New Orleans, LA
• Raftopoulos I, Giannakou A, Kandiliotis I, Bojkova M, Kupka T, Buzga M, Stecco K, Levy S, Gaur S, Chuttani R, Machytka E. The First Procedureless Gastric Balloon for Weight Loss: Final Results from a Multi-Center, Prospective Study Evaluating Safety, Efficacy, Participant Preference, and Long Term Follow-Up. 21st World Congress of International Federation for the Surgery of Obesity & Metabolic Disorders, Rio de Janeiro, Brazil, September 27-October 1, 2016.
• Giannakou A, Raftopoulos I, Chuttani R, Kandiliotis I, Stecco K, Kalogeris M, Levy S, Gaur S. Elipse™, a swallowable and procedureless gastric balloon for weight loss. Safety and efficacy outcomes. Scientific Forum, American College of Surgeons Clinical Congress, Washington DC, October 16-20, 2016.
• Machytka, E., Gaur, S.,  Chuttani, R.,  Bojkova, M.,  Kupka, T.,  Buzga, M.,  Giannakou, A.,  Ioannis, K.,  Stecco, K.,  Levy, S.,  Raftopoulos, I. The First Procedureless Gastric Balloon for Weight Loss: Final Results from a Multi-Center, Prospective Study Evaluating Safety, Efficacy, Metabolic Parameters, Quality of Life, and 6-month Follow-Up. 13th International Congress of Obesity, Vancouver, Canada, May 1-4, 2016.
• Chuttani, R., Machytka, E., Raftopoulos, I, Gaur, S.  The First Procedureless Gastric Balloon for Weight Loss: Final Results from a Multi-Center, Prospective Study Evaluating Safety, Efficacy, Metabolic Parameters, Quality of Life, and 6-month Follow-Up. Lecture presentation, Digestive Disease Week (DDW), San Diego (CA), May 21-24, 2016.
• Machytka E, Raftopoulos I, Brooks J, Levy S, Chuttani R, Gaur S. The emesis nemesis: A new combination anti-emetic therapy for gastric balloons. United European Gastroenterology Week, Barcelona, Spain, October 24-28, 2015.
• Raftopoulos I. Outcomes of laparoscopic Roux-en-Y gastric bypass as a primary versus revisional bariatric surgery. 40ο Panhellenic Medical Congress, Αthens 14-17 Μay 2014.
• Raftopoulos I. Indications for bariatric surgery Internal Medicine Congress, University Endocrinology Clinic “Sotiria” Hospital, Αthens April 4 2014.
• Raftopoulos I. Protein intake compliance of morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass and its effect on weight loss, leptin and albumin. 10ο Panhellenic Congress of the Greek Obesity Society, Αthens February 20-22 2014.
• Brian Pellini, Chhatrala, Ravi, Cushman Alexis, Judy Carty, Ioannis Raftopoulos. Feasibility and safety of a 1-day length of stay after primary and revisional laparoscopic Roux-en-Y gastric bypass in 538 consecutive patients. 29th Annual meeting of the Society for Metabolic and Bariatric Surgery, San Diego CA, June 17-22, 2012.

Κλινικό Ενδιαφέρον

• Ενδο-γαστρικό μπαλόνι Elipse για απώλεια βάρους (Το μοναδικό στον κόσμο που δεν απαιτεί ούτε γαστροσκόπηση, ούτε αναισθησία. Ο κος Ραυτόπουλος εφαρμόζει κατά αποκλειστικότητα αυτή την μεθόδο στην Ελλάδα)
• Χειρουργική Παχυσαρκίας
• Λαπαροσκοπική Χειρουργική
• Γενική Χειρουργική
• Άδειες εξασκήσεως ιατρικού επαγγέλματος:
• USA Drug Enforcement Agency (DEA): FR5686704 (2016 – έως σήμερα)
• Massachusetts license (professional license number): 265321 (2016 – έως σήμερα)
• MA Controlled Substances Registration #: MR1028516A (2016 – έως σήμερα)
• Ελλάδα (2004 – έως σήμερα)
• Ιστορικό μηνύσεων ιατρικής αστικής ευθύνης: Καμία σε Ελλάδα ή ΗΠΑ ενεργή ή στο παρελθόν (2003 – έως σήμερα)
• Κλινική εμπειρία άνω των 4000 επεμβάσεων χειρουργικής παχυσαρκίας και λαπαροσκοπικής χειρουργικής σε ΗΠΑ και Ελλάδα
• Εκτεταμένη εμπειρία σε λαπαροσκοπικές επεμβάσεις χολής, παχέος εντέρου, λεπτού εντέρου, κηλών
• Αποτελέσματα ανώτερα του μέσου όρου σε ΗΠΑ

Πίνακας 1: Σύγκριση ασφάλειας επεμβάσεων παχυσαρκίας του κου Ραυτόπουλου με την Αμερικανική Εθνική Τράπεζα δεδομένων MBSAQIP

Πίνακας 2: Σύγκριση απώλειας βάρους ύστερα από λαπαροσκοπικό γαστρικό μπαι-πας του κου Ραυτόπουλου με την Αμερικανική Εθνική Τράπεζα δεδομένων MBSAQIP

Πίνακας 3: Σύγκριση απώλειας βάρους ύστερα από λαπαροσκοπικό γαστρικό μανίκι του κου Ραυτόπουλου με την Αμερικανική Εθνική Τράπεζα δεδομένων MBSAQIP

Πίνακας 4: Σύγκριση απώλειας βάρους ύστερα από λαπαροσκοπικές διορθωτικές επεμβάσεις προηγούμενων επεμβάσεων παχυσαρκίας του κου Ραυτόπουλου με την Αμερικανική Εθνική Τράπεζα δεδομένων MBSAQIP

Πτυχίο Ιατρικής, Ιατρική Σχολή Αριστοτελείου Πανεπιστημίου Θεσσαλονίκης 1987 – 1993

• Ειδικότητα Γενικής Χειρουργικής, University of Illinois, USA 1996-2002
• Εξειδίκευση (Fellowship) στην Χειρουργική Παχυσαρκίας και Προχωρημένη Λαπαροσκοπική Χειρουργική Allegheny Health System and University of Pittsburgh 2002-2003, Pittsburgh, Pennsylvania, USA
• Πιστοποίηση στην Ρομποτική Χειρουργική DaVinci Robotic System (2013 – έως σήμερα)

• Verified Bariatric Surgeon, by the American College of Surgeons and American Society for Metabolic and Bariatric Surgery which reflects Expert’s experience in bariatric surgery 2017 – present
• Center of Excellence in Bariatric Surgery by the Surgical Review Corporation 2005 – 2013
• 2003 Resident Research award in recognition for outstanding research submission, Allegheny General Hospital
• Award for excellence (>90%) in the IN-Service United States General Surgery exam 1999 and 2002
• Nominated from my residency program for the SAGES Junior Research Award
• Honor of excellence at high school graduation year awarded by the Mayor of Athens
• Poster of distinction among 600 papers at the Society of American Gastrointestinal and Endoscopic Surgeons/World Congress of Endoscopic Surgery. Balaji Jangam, MD, Kristine O’Hara, MD,  Bruce Bernstein, PhD,  Ravi Chhatrala, MD, Ioannis Raftopoulos, MD, PhD, FACS. Outcomes of laparoscopic Roux-en-Y gastric bypass as a primary versus revisional bariatric surgery.
• Selected for oral presentation at the SSAT along with 37 other papers among 300 papers originally submitted: Raftopoulos IS, Ercole JA, Udekwu AO, Luketich J, Courcoulas AP. Short and long-term outcome of Roux-en-Y gastric bypass stratified by BMI of 70 Kg/m². A comparative analysis of 825 procedures. The Society for Surgery of the Alimentary Tract, New Orleans, LA, May 15-20, 2004.
• Best poster award: Santos RS, Raftopoulos Y, Singh D, Maley R, Keenan RJ, Landreneau RJ. Interventional bronchoscopy for management of benign tracheal stenosis. American College of Chest Physicians Orlando, FL, October 25-30, 2003.
• Nominee paper for Resident/Trainee Award: Raftopoulos Y, Papasavas P, Hayetian F, Maurer J, Bononi P, Caushaj P, Gagne D. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass. Presentation, American Society for Bariatric Surgery 20^th Annual Meeting, Boston June 2003.

1. Raftopoulos l, Giannakou A. The Elipse ballon, a swallowable gastric balloon for weight loss not requiring sedation, anesthesia or endoscopy: a pilot study with 12 month outcomes. Surg Obes Relat Dis. 2017;13(7):1174-1182.
2. Machytka E, Gaur S, Chuttani R, Bojkova M, Kupka T, Buzga M, Giannakou A, Kandiliotis I, Ma-thus-Vliegeni L, Levy S, Raftopoulos l. A Prospective, Observational, Open-Label Multi-Center Study Evaluating Safety, Efficacy, and Quality of Life. Endosc 2017;49:154-160.
3. Raftopoulos I. Author response to Dr. Pike’s letter to the editor titled “Fast track manage-ment after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg;2016;223(1):203-204.
4. Raftopoulos I, Giannakou A, Davidson E. Prospective 30-Day Outcome Evaluation of a Fast-Track Protocol for 23-Hour Ambulatory Primary and Revisional Laparoscopic Roux-en-Y Gastric Bypass in 820 Consecutive Unselected Patients. J Am Coll Surg;2016;222(6):1189-1200.
5. Raftopoulos I, Bernstein B, O’Hara KM, Ruby JA, Chhatrala R, Carty J. Protein intake compli-ance of morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass and its ef-fect on weight loss, leptin and albumin. Surgery for Obesity & Related Diseases 2011 Nov-Dec;7(6):733-42.
6. Raftopoulos I, Reed JF 3rd, Bergamaschi R. Circumferential resection margin involvement after laparoscopic abdominoperineal excision for rectal cancer. Colorectal Dis. 2012 Apr;14(4):431-7.
7. A Gorin, I Raftopoulos. Patients with combined mood and eating disorders who had laparo-scopic gastric bypass are more challenging postoperatively but can achieve comparable weight loss. Obes Surg 2009;19(12):1685-90.
8. Raftopoulos I, Bergamaschi R. Selection Criteria, Preoperative work-up and Postoperative Pathway for the Bariatric Surgery Patient in a U.S. center. Minimally Invasive Chirurgie (Accepted 6/25/2008)
9. Uchal M, Haughn C, Raftopoulos Y, Hussain F, Reed JF, Tjugum J, Bergamaschi R. Robotic camera holder as good as expert camera holder: a randomized crossover trial. Surg Laparosc Endosc & Percut Tech 2009;19(3):272-5.
10. Raftopoulos I, Martindale C, Cronin A, Steinberg J. The effect of extended post-discharge thromboprophylaxis on venous thromboembolism rates after bariatric surgery. A prospective comparison trial. Surg Endosc 2008 Nov;22(11):2384-91.

Τσόχα 23, Αθήνα, 2^ος Όροφος

Τηλ.: 210-641-6041

Κινητό: 6948-681-107

email: raftix23@gmail.com & Raftopoulos_Ioannis@holyokehealth.com